• <legend id="66666"><input id="66666"></input></legend>
  • <legend id="66666"></legend>
  • <tr id="66666"></tr>
  • <legend id="66666"><input id="66666"></input></legend>
    <legend id="66666"><sup id="66666"></sup></legend>
    <legend id="66666"><input id="66666"></input></legend>
    <center id="66666"><sup id="66666"></sup></center>

    18611095289

    down

    资料下载

    当前位置:首页资料下载人抗胰岛素IgG检测 Human Anti Insulin IgG ELISA Kit 说明书

    人抗胰岛素IgG检测 Human Anti Insulin IgG ELISA Kit 说明书

    发布时间:2023/11/15点击次数:391

    ADI.png

    人抗胰岛素IgG检测试剂盒

    Human Anti Insulin IgG ELISA Kit

    cat#3600-HIG

    INTENDED USE

    ADI’s Anti-Insulin ELISA Test Kit has been designed for the quantitative determination of

    Autoantibodies to Human Insulin in serum and plasma. The assay is useful for the

    determination of Type I Diabetes, as well as for screening purposes to detect developing

    insulin autoantibodies in monkey under insulin therapy.

    INTRODUCTION

    Type I Diabetes is mainly characterized by limited or fully missing secretion of the hormone

    insulin. Morphological studies demonstrated a destruction of the beta cells of the so-called

    Langerhanns's Cells (Islet Cells) in Type I diabetics. Numerous researchers described the

    appearance of antibodies directed against the islet cells and insulin as the causal reason

    for the onset of the disease. Anti-Insulin antibodies are found in 37 percent of patients with

    newly detected Type I Diabetes, in 4% of their relatives of the first degree and in up to

    1.5% of healthy controls. A positive correlation between the appearance of anti-Insulin and

    anti-Islet Cell antibodies has been reported. Anti-Insulin autoantibodies may be detected

    several months and in some cases years before the onset of the fully clinical manifestation

    of the diseases. Occasionally also autoantibodies to Pro-Insulin may appear. These ''true''

    anti-Insulin autoantibodies directed against endogenous insulin have to be distinguished

    from those autoantibodies which are developed in insulin dependent diabetics undergoing

    therapy with insulin preparations of animal origin. In fact the latter have to be referred to

    side effects. These side effects may occur as local reactions of the skin by development of

    insulin-specific autoantibodies. These autoantibodies are causing the formation of an

    insulin depot and they may simulate a resistance against the hormonal treatment with

    animal insulin. 

    SPECIFICITY and Animal Crossreactivity

    The microplate is coated with highly purified preparations of recombinant human insulin.

    The conjugate used in the kit is against the human IgG, therefore, only IgG-subclass

    antibodies will be detected. This kit will not detect anti-insulin IgG in other species. ADI

    has separate anti-insulin ELISA kits for monkey, mouse and rat samples.

    Standard Unit Calibration

    No international reference preparation for human anti-Insulin autoantibodies is available,

    the assay system is calibrated in relative arbitrary units.

    References: Jin, X (2010) Exp. Biol. Med. 235, 877-885; Koulmanda M (2003) Am. J.

    Transplant. 3, 267-272; Theriault BR (1999) Transplantation. 68:331-7 Wagner, JD (2001)

    Toxicol. Pathol. 29, 142-148; Reeves, W.G. et al (1983) Diabetologia, 24, 399; Atkinson,

    M.A., (1985) Diabetes 34, 926-930; Willein, T. (1985) Diabetes 76, 185; Kobayashi,

    N.(1985) J. Immunol. Methods 84; 245. Wissllein, T (1985) Lancet 1, 480; Soeldner, J.S.

    (1985) NEJM 313, 893.


    文件下载    

    服务热线
    18611095289

    扫码加微信

    免费无码又爽又刺激激情视频软件 <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <文本链> <文本链> <文本链> <文本链> <文本链> <文本链>